Monthly multiple injections of leukocyte-poor platelet-rich plasma (ACP®) for knee osteoarthritis: clinical effectiveness across KL grades, dose-response plateau at four, and 24-month durability
Under a fixed monthly protocol mirroring our LR-PRP schedule, ACP (LP-PRP) produced clinically meaningful improvements across KL1-4 with a practical evaluation horizon through the 4th injection and no clear per-session volume benefit of 6 mL over 3 mL. Prospective randomization of dose within a monthly-multiple framework is warranted.
Authors
- Masahiko Kemmochi (ORCID: https://orcid.org/0000-0003-4373-6854)
Publication Details
- Journal
- Regenerative Therapy
- Published
- 2026-01-20
- DOI
- https://doi.org/10.1016/j.reth.2026.101067
- Primary Topic
- Periodontal Regeneration and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00